Detalles de la búsqueda
1.
(3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1h-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitor with reduced myotoxicity potential.
J Med Chem
; 51(9): 2722-33, 2008 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-18412317
2.
Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis.
Thromb Res
; 123(1): 146-58, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18479740
3.
Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding.
Sci Transl Med
; 9(371)2017 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28053157
4.
Novel dual action AT1 and ETA receptor antagonists reduce blood pressure in experimental hypertension.
J Pharmacol Exp Ther
; 309(1): 275-84, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-14718594
Resultados
1 -
4
de 4
1
Próxima >
>>